Company intelligence / Profile preview

I-MED Animal Health

Montreal/Dollard Des Ormeaux/Saint-Laurent, Quebec, Canadaimedanimalhealth.com ↗

Ownership: Private
Employees: ~26
Development stage: Other

Overview

I-MED Animal Health offers a globally commercialized portfolio of veterinary ophthalmic products for the diagnosis and management of dry eye disease and other ocular surface disorders. Their signature lines—such as I-DROP VET PLUS artificial tears and I-LID ’N LASH VET eyelid cleansers—are widely used by veterinarians for effective relief of animal ocular conditions. The company has over three decades of R&D experience with a focus on innovation in veterinary eye care. No clinical trial data are published as these are medical devices/OTC products.

Therapeutic areas: DermatologyOphthalmology
Modalities: DeviceBiologicSmall moleculeNutritional supplement
Industry: Veterinary

Partnerships

NTC Srl (strategic partnership to bring HA-based dry eye ointment to US market)

Beyond the preview

Go deeper on I-MED Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on I-MED Animal Health.